T-cell immunoglobulin and ITIM domain, as a potential immune checkpoint target for immunotherapy of colorectal cancer.
IUBMB Life
; 73(5): 726-738, 2021 05.
Article
en En
| MEDLINE
| ID: mdl-33686787
Palabras clave
AML acute myelogenous leukemia; APCs antigen-presenting cells; CAFs cancer-associated fibroblasts; CRC colorectal cancer; DC Dendritic Cells; DFS disease-free survival; EMT epithelial-mesenchymal transition; ETBF Bacteroides fragilis; F. nucleatum Fusobacterium nucleatum; Fgl2 fibrinogen-like protein 2; Grb2 growth factor receptor-bound protein 2; IBD inflammatory bowel diseases; ICIs Immune checkpoint inhibitors; IHC immunohistochemistry; List of Abbreviations and symbols:; MAPK mitogen-activated protein kinase; MDSCs myeloid-derived suppressor cells; MSI Microsatellite instability; MSS microsatellite-stable; NFκB nuclear factor-kappa B; NK Natural Killer cell; NSCLC non-small cell lung cancer; PI3K phosphoinositide 3-kinase; PVR poliovirus receptor; RR-MS relapsing-remitting multiple sclerosis; SHIP1 SH2 domain-containing inositol-5-phosphatase 1; TAMs tumor-associated macrophages; TANs tumor-associated neutrophils; TFH follicular helper T cells; TFR follicular regulatory T cells; TIGIT; TIGIT T cell immunoglobulin and ITIM domain; TILs tumor-infiltrating lymphocytes; TME tumor microenvironment; TNM staging spread of cancer to other parts of the body; Tregs regulatory T cells; cancer immunotherapy; colorectal cancer; dMMR defective DNA mismatch repair; immune checkpoint; mAb monoclonal antibody
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Receptores Inmunológicos
/
Neoplasias Colorrectales
/
Adenocarcinoma
/
Inhibidores de Puntos de Control Inmunológico
/
Proteínas de Punto de Control Inmunitario
/
Inmunoterapia
Tipo de estudio:
Prognostic_studies
Límite:
Animals
/
Humans
Idioma:
En
Revista:
IUBMB Life
Asunto de la revista:
BIOLOGIA MOLECULAR
/
BIOQUIMICA
Año:
2021
Tipo del documento:
Article
País de afiliación:
Irán